Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2000
12/06/2000EP1056760A1 36 human secreted proteins
12/06/2000EP1056729A1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia
12/06/2000EP1056470A1 Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
12/06/2000EP1056455A1 Epimorphian compound and its use
12/06/2000CN1275979A Isoquinolines as urokinase inhibitors
12/06/2000CN1275912A Novel amide derivatives
12/06/2000CN1275402A Powder medicine for treating hyperosteogeny
12/06/2000CN1059120C Traditional Chinese medicine for treating injured bone
12/06/2000CN1059115C Medicinal compositions for treating osteoporosis
12/06/2000CN1059105C Medicine for treating arhtralgia-syndrome
12/06/2000CN1059100C Ointment for subsidence of swelling and relieving pain
12/06/2000CN1059096C Medicinal wine for treating injury and setting bone
12/06/2000CN1059091C Medicine for treating fracture and bone disease, and preparation process thereof
12/05/2000US6156878 Amino acid sequences; for antibodies, immunosuppressants, immunomodulators, immunotoxins, and diagnosis of related disorders
12/05/2000US6156799 Method of increasing bone volume using non-naturally-occurring FP selective agonists
12/05/2000US6156798 Cardiovascular disorders, nervous system disorders, antiarthritic disorders and enzyme inhibitors
12/05/2000US6156786 2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome
12/05/2000US6156735 Arginine silicate inositol complex and use thereof
12/05/2000US6156523 Serine/threonine protein kinases
12/05/2000CA2188066C Thio-substituted phosphonate compounds
12/05/2000CA2136822C Thio-substituted cyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/01/2000CA2310272A1 Transdermal estrogen agonist-antagonist therapy
11/2000
11/30/2000WO2000071585A1 Human antibodies to staphylococcus aureus
11/30/2000WO2000071584A1 Seven transmembrane receptor genes
11/30/2000WO2000071560A1 Methods of modulating activity of prokaryotic ribosomes
11/30/2000WO2000071549A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000WO2000071548A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000WO2000071540A1 Hydrochloride of fused-heterocycle compound
11/30/2000WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
11/30/2000WO2000071537A1 New pharmaceutically active compounds
11/30/2000WO2000071535A1 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
11/30/2000WO2000071529A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
11/30/2000WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS
11/30/2000WO2000071160A1 MEDICINAL COMPOSITIONS CONTAINING ANTI-Fas ANTIBODY
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071148A2 Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin
11/30/2000WO2000071140A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000WO2000071104A2 Use of bisphosphonic acids for treating angiogenesis
11/30/2000WO2000071103A2 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
11/30/2000WO2000042172A3 Human homologues of proteins regulated by circadian rhythms
11/30/2000WO2000041725A3 Therapeutic compositions for metabolic bone disorders or bone metastases
11/30/2000WO2000028027A3 Corticosteroid synthesis-associated genes
11/30/2000WO2000028019A3 Antisense oligomer
11/30/2000DE19923961A1 Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
11/30/2000CA2381441A1 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
11/30/2000CA2374926A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000CA2374915A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374301A1 Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin
11/30/2000CA2374049A1 Use of bisphosphonic acids for treating angiogenesis
11/30/2000CA2373992A1 Medicinal compositions containing anti-fas antibody
11/30/2000CA2373693A1 Seven transmembrane receptor genes
11/30/2000CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds
11/30/2000CA2373221A1 Human antibodies to staphylococcus aureus
11/30/2000CA2372743A1 New pharmaceutically active compounds
11/30/2000CA2372580A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
11/30/2000CA2372567A1 Indole-type derivatives as inhibitors of p38 kinase
11/29/2000EP1055658A2 Process for cis-1- 2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl pyrrolidine
11/29/2000EP1054968A1 Apoptosis inducing molecule ii and methods of use
11/29/2000EP1054905A1 Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg
11/29/2000EP1054904A1 Mucilage, a g-protein-coupled receptor
11/29/2000EP1054887A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
11/29/2000EP1054886A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
11/29/2000EP1054884A1 Benzofuran-4-carboxamides and their therapeutic use
11/29/2000EP1054877A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
11/29/2000EP1054871A2 Pyrimidines and triazines as integrin antagonists
11/29/2000EP1054869A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
11/29/2000EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
11/29/2000EP1054857A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/29/2000EP1054692A2 Antibodies against human cd40
11/29/2000EP1054671A1 New use for pain management
11/29/2000CN1275123A Prostaglandin agonists and their use to treat bone disorders
11/29/2000CN1274603A Externally-used arthralgia treating medicine and its preparation
11/29/2000CN1274602A Externally applied medicated wine for treating traumatic injury and rheumatism
11/29/2000CN1274597A Hyperosteogeny treating medicine
11/29/2000CN1274590A Plaster for treating hyperosteogeny and protrusion of lumber ertebral disc
11/29/2000CN1274586A Burn and scald treating external-use ointment
11/29/2000CN1274583A Calcium replenishing agent containing composite trace elements
11/29/2000CN1058896C Oral liquor for would and preparation thereof
11/29/2000CN1058889C External-use ointment for treating atrophic arthritis
11/29/2000CN1058888C External-use ointment for treating pathological changes of intervertebral disc
11/29/2000CN1058884C Effective medicine composition for treatment of rheumatism and its capsule
11/29/2000CN1058872C Method of producing medicine for treatment of chronic osteomyelitis
11/29/2000CN1058867C Drug composition for curing bone tuberculosis in fumigation
11/28/2000US6153628 1,3,4-thiadiazoles and 1,3,4-Oxadiazoles as αv β3 antagonists
11/28/2000US6153615 Administering nitric oxide synthesis inhibiting amount of dihydrofolate reductase inhibitor, catecholamine replacing non-toxic amount of levodopa with or without carbidopa and serotonin replacing non-toxic amount of l-5-hydroxytryptophane
11/28/2000US6153609 Arylsulfonylamino hydroxamic acid derivatives
11/28/2000US6153605 Useful in treatment or prevention of vitamin d dependent disorders, particularly psoriasis, basal cell carcinomas, disorders of keratinization and keratosis, leukemia, osteoporosis, hyperparathyroidism accompanying renal failure
11/28/2000US6153225 Injectable formulations of nanoparticulate naproxen
11/28/2000US6153200 Administering an isolated and purified bacterial dnajp1 peptide having the amino acid sequence
11/28/2000CA2309434A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/28/2000CA2046308C Radiolabeled colloid compositions, their use and process for their preparation
11/23/2000WO2000070091A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF HUMAN PROTEIN KINASE C-δ EXPRESSION
11/23/2000WO2000070060A1 Production of complex carbohydrates
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070046A2 Secreted polypeptides and corresponding polynucleotides
11/23/2000WO2000070045A1 Ox2 receptor homologs
11/23/2000WO2000070042A1 143 human secreted proteins
11/23/2000WO2000070025A1 Methods of using rnase p reaction mechanisms of action
11/23/2000WO2000069861A1 THIAZOLOPYRIMIDINES USEFUL AS TNFα INHIBITORS
1 ... 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 ... 820